Compare Supplements

30mg elemental iron

Between meals

Ferrous bisglycinate (gentle, well-absorbed) or iron protein succinylate

INVESTIGATIONAL — no approved consumer dose. In trials, once-daily oral orforglipron was titrated up to 36 mg (some phase-2 cohorts to 45 mg) with gradual dose escalation to limit GI side effects. Not for self-administration; only appropriate within a clinical trial or, if/when approved, under a prescribing clinician.

Any time

Oral tablet (investigational)

• Hemochromatosis or iron overload
• Repeated blood transfusions
• Adequate iron stores (test first!)

• Thyroid medications (levothyroxine)
• Antacids, PPIs
• Antibiotics (fluoroquinolones, tetracyclines)

• Not an approved medicine — only appropriate within a clinical trial or, if/when approved, under a clinician
• Expected: personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) — the GLP-1-class thyroid C-cell concern
• History of pancreatitis (caution, consistent with the GLP-1 class)

• Insulin and sulfonylureas
• Oral medications (general)
• Other GLP-1 receptor agonists